09886.HK
Dingdang Health Technology Group Ltd.
HKSE · Consumer Defensive · Household & Personal Products · CN
HKD 0.88
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.0B | 4.9B | 4.7B | 4.9B | 4.3B |
| Cost of Revenue | 3.2B | 3.2B | 3.1B | 3.3B | 2.9B |
| Gross Profit | 1.8B | 1.7B | 1.5B | 1.5B | 1.4B |
| Operating Expenses | |||||
| R&D Expense | 52.4M | 54.4M | 61.2M | 65.0M | 89.0M |
| SG&A Expense | 1.7B | 1.3B | 1.2B | 1.2B | 1.2B |
| General & Admin Expense | 138.3M | 173.6M | 229.7M | 258.7M | 334.5M |
| Selling & Marketing Expense | 1.1B | 1.1B | 1.0B | 972.7M | 908.2M |
| Other Expenses | — | 449.6M | 449.4M | 492.6M | 436.5M |
| Total Operating Expenses | 1.8B | 1.8B | 1.8B | 1.8B | 1.8B |
| Cost and Expenses | 5.0B | 4.9B | 4.9B | 5.1B | 4.6B |
| Operating Income (EBIT) | 10.9M | (53.4M) | (217.2M) | (278.2M) | (326.4M) |
| Non-Operating | |||||
| Interest Income | — | 27.9M | 28.7M | 32.6M | 17.2M |
| Interest Expense | — | 12.4M | 8.9M | 7.9M | 7.9M |
| Net Interest Income | 13.4M | 15.5M | 19.8M | 24.7M | 9.2M |
| Other Non-Op Income/Expense | (56.0M) | 22.7M | (154.9M) | 57.0M | (2.5B) |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (45.1M) | (30.7M) | (370.1M) | (221.2M) | (2.8B) |
| Income Tax Expense | 19.9M | 21.4M | 9.9M | 9.6M | 10.1M |
| Bottom Line | |||||
| Net Income | (61.7M) | (49.0M) | (376.5M) | (225.8M) | (2.8B) |
| Earnings from Cont. Ops | (65.0M) | (52.1M) | (380.0M) | (230.9M) | (2.8B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (61.7M) | (49.0M) | (376.5M) | (225.8M) | (2.8B) |
| Per Share | |||||
| Basic EPS | (HK$0.05) | (HK$0.04) | (HK$0.29) | (HK$0.17) | (HK$2.10) |
| Diluted EPS | (HK$0.05) | (HK$0.04) | (HK$0.29) | (HK$0.17) | (HK$2.10) |
| Revenue Per Share | HK$3.95 | HK$3.76 | HK$3.53 | HK$3.63 | HK$3.23 |
| Shares | |||||
| Basic Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted Shares Outstanding | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B |
| Profitability Metrics | |||||
| EBITDA | 153.0M | 87.3M | (78.9M) | (73.3M) | (191.1M) |
| D&A | 142.1M | 140.7M | 138.3M | 140.0M | 135.3M |
| EBIT | 10.9M | (53.4M) | (217.2M) | (213.3M) | (326.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026